Latuda is a prescription medication classified as an atypical antipsychotic. Its active ingredient lurasidone works by selectively blocking dopamine d2 receptors and serotonin 5-ht1a receptors in the brain. This selective receptor profile helps regulate the balance of neurotransmitters involved in mood and perception. By modulating dopamine activity it reduces excessive signaling that can contribute to hallucinations and delusions. Activation of 5-ht1a receptors enhances serotonergic transmission which can improve depressive symptoms when used with an antidepressant. The combined effect stabilizes cognition and emotional processing in patients with schizophrenia or major depressive disorder. Overall the drug aims to correct underlying neurochemical disturbances that drive psychotic and depressive manifestations.

Latuda is an atypical antipsychotic medication used to treat schizophrenia and bipolar depression. Its active ingredient is lurasidone, which works by selectively blocking serotonin and dopamine receptors to restore neurotransmitter balance. By antagonizing 5-ht1a and 5-ht2a receptors it reduces overactive serotonergic signaling that contributes to mood and psychotic symptoms. It also blocks d2 receptors in the mesolimbic pathway, helping to diminish hallucinations and delusions without excessive motor side effects. The drug's partial agonist activity at 5-ht1d receptors further stabilizes mood regulation in bipolar patients. These combined actions make Latuda effective in improving psychiatric symptoms through targeted receptor modulation.

Latuda may cause drowsiness in some individuals. It can lead to weight gain that varies among users. Nausea is reported by a minority of patients. Some people experience dizziness or lightheadedness, especially when standing quickly. Changes in blood sugar levels have been observed in rare cases. The medication can occasionally cause involuntary muscle movements such as tremor or restlessness. Sensitivity to temperature may increase for certain users. Overall, the range of effects is diverse and not universally experienced.

Latuda may cause drowsiness in some patients. Weight gain can occur as the medication affects metabolism. Nausea and occasional vomiting are reported side effects. Some individuals experience dizziness or lightheadedness when standing up quickly. Headaches are also observed during treatment. Elevated blood cholesterol levels have been noted in certain patients. Tremors or shaking of the hands may appear in a small number of cases. Rarely, patients report constipation accompanied by abdominal discomfort.